Article
[Hereditary breast cancer: treatment and prevention].
Ugeskrift for laeger - 3 Sept 2007
Ejlertsen Bent, Gerdes Anne-Marie A
Abstract excerpt
In general, the treatment of early breast cancer is guided by the results from large randomised trials. The same does not apply to patients who carry BRCA1/2 mutations. The selection of loco-regional therapies might change according to BRCA1/2 mutation status. In order to reduce the risk of secondary breast and ovarian cancer, these patients may also be offered prophylactic oophorectomy. The possible impact of...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
